Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (TARS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TARS · as of Jun 9, 2026
Key Statistics
Explore Tarsus Pharmaceuticals, Inc. Data
tars stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 88.9%
The TARS analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $84.00, representing +40.85% upside from the current price of $59.64.
Competitors & Peers
tars competitorsTARS
AAPG
ADPT
ARQT
CELC
CGONStock Performance
Full HistoryAbout Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigat…
what is tarsus pharmaceuticals, inc. · tars stock overview · tarsus pharmaceuticals, inc. company profile · who is tarsus pharmaceuticals, inc. ceo · tars NASDAQ · tarsus pharmaceuticals, inc. headquarters · tarsus pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Tarsus Pharmaceuticals, Inc. (TARS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 16, 2020. As of the latest trading session, TARS stock price is $59.64, with a market capitalization of $2.6B. The stock has returned +36.91% over the past 12 months and -27.92% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Tarsus Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $84.00. In fiscal year 2025, Tarsus Pharmaceuticals, Inc. reported revenue of $451.4M and net income of -$66.4M. For detailed data — including Tarsus Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Tarsus Pharmaceuticals, Inc. (TARS) stock price is $59.64. The stock is traded on NASDAQ under the ticker symbol TARS. The 52-week range is $38.51 – $85.25.